High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell TumorsYago Nieto, Matthew T. Campbell, John F. Ward et al.|Clinical Cancer Research|2025Cited by 2
Patient Reported Toxicity, Quality of Life and Biochemical Control Following HDR Brachytherapy: Outcomes from the First 2 Years of a New Service at the Sussex Cancer CentreSharon A. Appleyard, Ashok Nikapota, F. Cowtan et al.|Clinical Oncology|2019Cited by 0
Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK CentreC. Lorimer, Ashok Nikapota, Andrew Johns et al.|Clinical Oncology|2023Cited by 0